Early diagnosis of cardiac amyloidosis (CA) can prevent irreversible heart damage, guide appropriate disease management and improve quality of life and prognosis. The complexity of diagnostic techniques, however, can made CA detection extremely challenging.
Ultrasonics is an England-based AI-enabled medical imaging company that offers echo analysis and ultrasound imaging solutions to detect and treat cardiovascular diseases.